Management of anemia in chronic kidney disease

Abstract

Anemia is the most common complication of chronic kidney disease (CKD) associated with reduced quality of life and increased morbidity and mortality. The purpose of this review was to discuss the management of anemia in CKD. The following topics are considered: prevalence of anemia, symptoms, and impact of anemia in CKD, diagnosis, iron replacement therapy, and erythropoiesis-stimulating agents.

Keywords

• chronic kidney disease, anemia, erythropoiesis-sti­mulating agents, epobiocrinum